HNF4A and PCBD1 |
hepatocyte nuclear factor 4, alpha |
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Phenylalanine and tyrosine catabolism
- Metabolism of amino acids and derivatives
|
|
|
|
|
HNF4A and TRIM24 |
hepatocyte nuclear factor 4, alpha |
tripartite motif containing 24 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Signaling by FGFR in disease
- Signaling by FGFR1 mutants
- Signaling by FGFR mutants
- Signaling by FGFR1 fusion mutants
|
|
|
|
|
HNF4A and COPS5 |
hepatocyte nuclear factor 4, alpha |
COP9 signalosome subunit 5 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
|
HNF4A and ZNHIT3 |
hepatocyte nuclear factor 4, alpha |
zinc finger, HIT-type containing 3 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
|
HNF4A and NR0B2 |
hepatocyte nuclear factor 4, alpha |
nuclear receptor subfamily 0, group B, member 2 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
HNF4A and NR2F1 |
hepatocyte nuclear factor 4, alpha |
nuclear receptor subfamily 2, group F, member 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
HNF4A and NR1I3 |
hepatocyte nuclear factor 4, alpha |
nuclear receptor subfamily 1, group I, member 3 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
|
HNF4A and SIRT1 |
hepatocyte nuclear factor 4, alpha |
sirtuin 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Epigenetic regulation of gene expression
- Negative epigenetic regulation of rRNA expression
- SIRT1 negatively regulates rRNA Expression
- Cellular response to heat stress
- Regulation of HSF1-mediated heat shock response
|
|
|
|
|
HNF4A and TP53 |
hepatocyte nuclear factor 4, alpha |
tumor protein p53 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Cellular Senescence
- Activation of BH3-only proteins
- p53-Dependent G1/S DNA damage checkpoint
- Oncogene Induced Senescence
- p53-Dependent G1 DNA Damage Response
- Formation of Senescence-Associated Heterochromatin Foci (SAHF)
- Pre-NOTCH Transcription and Translation
- Stabilization of p53
- Transcriptional activation of p53 responsive genes
- Programmed Cell Death
- Pre-NOTCH Expression and Processing
- G1/S DNA Damage Checkpoints
- Intrinsic Pathway for Apoptosis
- Transcriptional activation of cell cycle inhibitor p21
- DNA Damage/Telomere Stress Induced Senescence
- Signaling by NOTCH
- Factors involved in megakaryocyte development and platelet production
- Activation of NOXA and translocation to mitochondria
- Oxidative Stress Induced Senescence
- Autodegradation of the E3 ubiquitin ligase COP1
- Activation of PUMA and translocation to mitochondria
- Cell Cycle Checkpoints
|
|
|
|
|
HNF4A and SMAD2 |
hepatocyte nuclear factor 4, alpha |
SMAD family member 2 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Loss of Function of TGFBR2 in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- TGFBR1 LBD Mutants in Cancer
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Generic Transcription Pathway
- Signaling by NODAL
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- Loss of Function of SMAD2/3 in Cancer
- Signaling by Activin
- TGFBR2 Kinase Domain Mutants in Cancer
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- Loss of Function of TGFBR1 in Cancer
- Signaling by TGF-beta Receptor Complex in Cancer
- Signaling by TGF-beta Receptor Complex
- SMAD4 MH2 Domain Mutants in Cancer
|
|
|
|
|
HNF4A and SMAD3 |
hepatocyte nuclear factor 4, alpha |
SMAD family member 3 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Loss of Function of TGFBR2 in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- TGFBR1 LBD Mutants in Cancer
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Generic Transcription Pathway
- Signaling by NODAL
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- Loss of Function of SMAD2/3 in Cancer
- Signaling by Activin
- TGFBR2 Kinase Domain Mutants in Cancer
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- Loss of Function of TGFBR1 in Cancer
- Signaling by TGF-beta Receptor Complex in Cancer
- Signaling by TGF-beta Receptor Complex
- SMAD4 MH2 Domain Mutants in Cancer
|
|
|
|
|
HNF4A and SMAD4 |
hepatocyte nuclear factor 4, alpha |
SMAD family member 4 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Loss of Function of TGFBR2 in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- TGF-beta receptor signaling activates SMADs
- TGFBR1 LBD Mutants in Cancer
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Signaling by BMP
- Transcriptional regulation of pluripotent stem cells
- Generic Transcription Pathway
- Signaling by NODAL
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- Loss of Function of SMAD2/3 in Cancer
- Signaling by Activin
- TGFBR2 Kinase Domain Mutants in Cancer
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- Loss of Function of TGFBR1 in Cancer
- Signaling by TGF-beta Receptor Complex in Cancer
- Signaling by TGF-beta Receptor Complex
- SMAD4 MH2 Domain Mutants in Cancer
|
|
|
|
|
HNF4A and RNF4 |
hepatocyte nuclear factor 4, alpha |
ring finger protein 4 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Antigen processing: Ubiquitination & Proteasome degradation
- Class I MHC mediated antigen processing & presentation
- Adaptive Immune System
|
|
|
|
|
HNF4A and TGS1 |
hepatocyte nuclear factor 4, alpha |
trimethylguanosine synthase 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Organelle biogenesis and maintenance
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Metabolism of non-coding RNA
- REV-ERBA represses gene expression
- RORA activates circadian gene expression
- Mitochondrial biogenesis
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- Generic Transcription Pathway
- snRNP Assembly
- Transcriptional regulation of white adipocyte differentiation
- YAP1- and WWTR1 (TAZ)-stimulated gene expression
- Activation of gene expression by SREBF (SREBP)
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- Transcriptional activation of mitochondrial biogenesis
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- Orphan transporters
|
|
|
|
|
HNRNPD and IGF2BP2 |
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) |
insulin-like growth factor 2 mRNA binding protein 2 |
- Processing of Capped Intron-Containing Pre-mRNA
- mRNA Splicing
- mRNA Splicing - Major Pathway
|
- Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
|
|
|
|
|
HSPA5 and MTNR1B |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
melatonin receptor 1B |
- Platelet degranulation
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
- ATF6-alpha activates chaperone genes
- IRE1alpha activates chaperones
- Response to elevated platelet cytosolic Ca2+
- Class I MHC mediated antigen processing & presentation
- Platelet activation, signaling and aggregation
- ATF6-alpha activates chaperones
- PERK regulates gene expression
- Unfolded Protein Response (UPR)
- Adaptive Immune System
|
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- GPCR downstream signaling
- Class A/1 (Rhodopsin-like receptors)
- G alpha (i) signalling events
- Metabolic disorders of biological oxidation enzymes
- GPCR ligand binding
|
|
- Ramelteon
- Melatonin
- Agomelatine
|
|
|
HSPB1 and INS |
heat shock 27kDa protein 1 |
insulin |
- Regulation of mRNA stability by proteins that bind AU-rich elements
- Signaling by VEGF
- AUF1 (hnRNP D0) destabilizes mRNA
- VEGFA-VEGFR2 Pathway
|
- Synthesis, secretion, and deacylation of Ghrelin
- Insulin receptor signalling cascade
- Integration of energy metabolism
- Regulation of insulin secretion
- IRS-related events
- SHC-related events
- Insulin receptor recycling
- Peptide hormone metabolism
- IRS activation
- Regulation of beta-cell development
- Signal attenuation
- Regulation of gene expression in beta cells
- Insulin processing
- SHC activation
- Signaling by Insulin receptor
|
|
|
|
|
ICAM1 and IL2RA |
intercellular adhesion molecule 1 |
interleukin 2 receptor, alpha |
- Interferon gamma signaling
- Interferon Signaling
- Cytokine Signaling in Immune system
- Integrin cell surface interactions
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Adaptive Immune System
|
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- Signaling by Interleukins
- GPCR downstream signaling
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
|
- Denileukin diftitox
- Aldesleukin
- Basiliximab
- Daclizumab
|
|
|
ICAM3 and PRKCQ |
intercellular adhesion molecule 3 |
protein kinase C, theta |
- Integrin cell surface interactions
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Adaptive Immune System
|
- G alpha (q) signalling events
- Signaling by GPCR
- Downstream TCR signaling
- Axon guidance
- Effects of PIP2 hydrolysis
- FCERI mediated NF-kB activation
- Inactivation, recovery and regulation of the phototransduction cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- The phototransduction cascade
- Programmed Cell Death
- G alpha (z) signalling events
- Netrin-1 signaling
- Innate Immune System
- Apoptotic cleavage of cellular proteins
- Apoptotic execution phase
- Diseases associated with visual transduction
- G alpha (q) signalling events
- GPCR downstream signaling
- TCR signaling
- Visual phototransduction
- Fc epsilon receptor (FCERI) signaling
- Platelet activation, signaling and aggregation
- Adaptive Immune System
|
|
- Staurosporine
- Phosphonothreonine
- Phosphonoserine
|
|
|
IFNA1 and IL2 |
interferon, alpha 1 |
interleukin 2 |
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Regulation of IFNA signaling
- Interferon Signaling
- TRAF6 mediated IRF7 activation
- Cytokine Signaling in Immune system
- Interferon alpha/beta signaling
- Factors involved in megakaryocyte development and platelet production
- Innate Immune System
|
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- Signaling by Interleukins
- GPCR downstream signaling
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
|
- SP4160
- 5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid
- 3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One
- (R)-N-[2-[1-(Aminoiminomethyl)-3-Piperidinyl]-1-Oxoethyl]-4-(Phenylethynyl)-L-Phenylalanine Methylester
- (1h-Indol-3-Yl)-(2-Mercapto-Ethoxyimino)-Acetic Acid
- SP2456
- 2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide
|
|
|